Vintor®
Acute myocardial infarction
ApprovedCommercial
Key Facts
About Gennova Bio
Indian biotech delivering a portfolio of recombinant therapeutics and mRNA vaccines through innovative, scalable manufacturing.
View full company profileTherapeutic Areas
Other Acute myocardial infarction Drugs
| Drug | Company | Phase |
|---|---|---|
| VDAC1 Platform | Abarceo Pharma | Preclinical |
| OP2113 | CVasThera | Pre-clinical |
| MSC-based Therapy | Kyttaro | Pre-clinical |
| Selatogrel | Idorsia | Phase 3 |